Search research articles
Contact Us
Filters
Showing results (41-50 of 111) with videos related to
Page
of 12
Sort By:
Pediatric Blood & Cancer
|
September 3, 2013
Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95
Meriel Jenney, Odile Oberlin, Georges Audry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy
Julia C Chisholm, Julien Marandet, Annie Rey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2010
Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood
Markhaba Tukenova, Catherine Guibout, Mike Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2007
Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology
Marie-Pierre Castex, Hervé Rubie, Michael C G Stevens, et al.
International Journal of Cancer
|
October 3, 2006
Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study
Sylvie Guérin, Catherine Guibout, Akthar Shamsaldin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
Edoardo Missiaglia, Dan Williamson, Julia Chisholm, et al.
Pediatric Blood & Cancer
|
April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcoma
Angela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Cancer
|
May 26, 2007
Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma
Christine Mauz-Körholz, Stephanie Gorde-Grosjean, Dirk Hasenclever, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2012
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
Cormac Owens, Valerie Laurence, Lofti Benboubker, et al.
Pediatric Blood & Cancer
|
August 11, 2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups
Odile Oberlin, Annie Rey, Kenneth L B Brown, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 111) with videos related to
Sort By:
Page
of 12
Pediatric Blood & Cancer
|
September 3, 2013
Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95
Meriel Jenney, Odile Oberlin, Georges Audry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy
Julia C Chisholm, Julien Marandet, Annie Rey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2010
Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood
Markhaba Tukenova, Catherine Guibout, Mike Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2007
Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology
Marie-Pierre Castex, Hervé Rubie, Michael C G Stevens, et al.
International Journal of Cancer
|
October 3, 2006
Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study
Sylvie Guérin, Catherine Guibout, Akthar Shamsaldin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
Edoardo Missiaglia, Dan Williamson, Julia Chisholm, et al.
Pediatric Blood & Cancer
|
April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcoma
Angela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Cancer
|
May 26, 2007
Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma
Christine Mauz-Körholz, Stephanie Gorde-Grosjean, Dirk Hasenclever, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2012
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
Cormac Owens, Valerie Laurence, Lofti Benboubker, et al.
Pediatric Blood & Cancer
|
August 11, 2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups
Odile Oberlin, Annie Rey, Kenneth L B Brown, et al.
Page
of 12